Literature DB >> 16493539

Long-term survival after incomplete resection of immunohistochemically diagnosed T0N1 lung cancer: report of a case.

Yotaro Izumi1, Makio Mukai, Koji Kikuchi, Koichi Kobayashi.   

Abstract

A 63-year-old man who had undergone resection of colon cancer 15 years previously was found to have a right hilar mass on chest X-ray, and an elevated serum carcinoembryonic antigen level. The hilar lymph nodes were resected with the right upper lobe, and the initial diagnosis was colon cancer metastasis to the right hilar lymph nodes. Although the resection was incomplete, and no additional treatment was given, the patient remained free of recurrence for 10 years. This prompted us to reconsider our diagnosis using immunohistochemistry. The resected lymph nodes were found to be positive for thyroid transcription factor 1 (TTF-1) and cytokeratin 7, and negative for surfactant apoprotein (SAP), cytokeratin 20, and napsin A. The neuroendocrine markers and thyroglobulin were also negative. These findings led us to diagnose T0N1 lung cancer. There are reports of patients with clinical T0N1,2 lung cancer having exceptionally good prognoses despite noncurative treatment; however, to our knowledge, this is the first case of a patient with T0N1 lung cancer diagnosed by immunohistochemistry, with a good prognosis despite incomplete resection. In this case, TTF-1 and cytokeratin staining was particularly helpful in the differential diagnosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16493539     DOI: 10.1007/s00595-005-3147-8

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  13 in total

Review 1.  [Mediastinal lymph-node carcinoma with no apparent primary lesion].

Authors:  Y Masaki; M Gomibuchi; S Tanaka; T Sasai
Journal:  Kyobu Geka       Date:  1997-08

2.  Recurrence of rectal carcinoma in the mediastinum.

Authors:  C M Satur; C Gebitekin; P E Da Costa; N R Saunders
Journal:  South Med J       Date:  1993-06       Impact factor: 0.954

3.  ACUPS (adenocarcinoma of unknown primary site): a clinical and cost benefit analysis.

Authors:  C S Hamilton; A O Langlands
Journal:  Int J Radiat Oncol Biol Phys       Date:  1987-10       Impact factor: 7.038

4.  Metastatic carcinomas from occult primary tumors. A study of 254 patients.

Authors:  M S Didolkar; N Fanous; E G Elias; R H Moore
Journal:  Ann Surg       Date:  1977-11       Impact factor: 12.969

5.  Diagnostic markers that distinguish colon and ovarian adenocarcinomas: identification by genomic, proteomic, and tissue array profiling.

Authors:  Satoshi Nishizuka; Sing-Tsung Chen; Fuad G Gwadry; Jes Alexander; Sylvia M Major; Uwe Scherf; William C Reinhold; Mark Waltham; Lu Charboneau; Lynn Young; Kimberly J Bussey; Sohyoung Kim; Samir Lababidi; Jae K Lee; Stefania Pittaluga; Dominic A Scudiero; Edward A Sausville; Peter J Munson; Emmanuel F Petricoin; Lance A Liotta; Stephen M Hewitt; Mark Raffeld; John N Weinstein
Journal:  Cancer Res       Date:  2003-09-01       Impact factor: 12.701

6.  Usefulness of TA02 (napsin A) to distinguish primary lung adenocarcinoma from metastatic lung adenocarcinoma.

Authors:  Takashi Hirano; Yunbo Gong; Koichi Yoshida; Yasufumi Kato; Koich Yashima; Masahiro Maeda; Ayako Nakagawa; Kaoru Fujioka; Tatsuo Ohira; Norihiko Ikeda; Yoshiro Ebihara; Gert Auer; Harubumi Kato
Journal:  Lung Cancer       Date:  2003-08       Impact factor: 5.705

7.  An analysis of 1539 patients with cancer of unknown primary site.

Authors:  E Altman; E Cadman
Journal:  Cancer       Date:  1986-01-01       Impact factor: 6.860

8.  [Solitary rectal carcinoma metastasis to the left hilar lymph nodes: a case report].

Authors:  J Nakajima; Y Kotsuka; K Yagyuu; T Kohno; T Ohtsuka; K Tanbara; A Furuse; N Ohishi; T Oka; H Okaniwa
Journal:  Nihon Kyobu Shikkan Gakkai Zasshi       Date:  1995-02

9.  Unknown primary adenocarcinoma: incidence of overinvestigation and natural history.

Authors:  J F Stewart; M H Tattersall; R L Woods; R M Fox
Journal:  Br Med J       Date:  1979-06-09

10.  Utility of cytokeratin immunostaining in separating pulmonary adenocarcinomas from colonic adenocarcinomas.

Authors:  T S Loy; R D Calaluce
Journal:  Am J Clin Pathol       Date:  1994-12       Impact factor: 2.493

View more
  2 in total

Review 1.  Selection of extreme phenotypes: the role of clinical observation in translational research.

Authors:  José Luis Pérez-Gracia; Alfonso Gúrpide; María Gloria Ruiz-Ilundain; Carlos Alfaro Alegría; Ramon Colomer; Jesús García-Foncillas; Ignacio Melero Bermejo
Journal:  Clin Transl Oncol       Date:  2010-03       Impact factor: 3.405

2.  Lymph node cancer of the mediastinum with a putative necrotic primary lesion in the lung: a case report.

Authors:  Daichi Shikata; Takahiro Nakagomi; Rumi Higuchi; Yujiro Yokoyama; Toshio Oyama; Taichiro Goto
Journal:  World J Surg Oncol       Date:  2018-04-02       Impact factor: 2.754

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.